mProX™ Human CDK5 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryBased on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.
Product Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Kevin
Verified Customer
Charles
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Function of CDK5 in different subcellular locations.
The current study first overexpressed EGFP-CDK5-WT, EGFP-CDK5-NLS, EGFP-CDK5-NES, or p-TRE-EGFP in the HGC-27 GC cell line in order to investigate the function of CDK5 in various subcellular sites. Then, CCK-8 and SRB experiments were run, and the results showed that nuclear CDK5 expression dramatically reduced cell proliferation and colony formation.
Ref: Lu, Jun, et al. "CDK5 suppresses the metastasis of gastric cancer cells by interacting with and regulating PP2A." Oncology Reports 41.2 (2019): 779-788.
Pubmed: 30431123
DOI: 10.3892/or.2018.6860
Research Highlights
Recent discoveries on the molecular interactions that control CDK5 activity and the pathways connected to CDK5 that are linked to a number of disorders are included in this review.
Shupp, Alison, Mathew C. Casimiro, and Richard G. Pestell. "Biological functions of CDK5 and potential CDK5 targeted clinical treatments." Oncotarget 8.10 (2017): 17373.
Pubmed:
28077789
DOI:
10.18632/oncotarget.14538
When cells are treated with the CDK5 inhibitor roscovitine, they become more susceptible to heat-induced apoptosis and its phosphorylation, which stops the actions of apoptotic proteins.
Roufayel, Rabih, and Nimer Murshid. "CDK5: key regulator of apoptosis and cell survival." Biomedicines 7.4 (2019): 88.
Pubmed:
31698798
DOI:
10.3390/biomedicines7040088